Blood Sugar, Respiratory Health, and Anti-Inflammatory Benefits

How loquat leaf triterpenoids and polyphenols support blood sugar regulation, respiratory health, and systemic anti-inflammatory activity

Loquat (Eriobotrya japonica) is a subtropical fruit tree whose small, golden-orange fruits have a sweet-tart flavor somewhere between apricot and peach. While the fruit is enjoyed fresh throughout Asia and the Mediterranean, the leaves have been used in traditional Chinese and Japanese medicine for centuries — particularly for coughs, blood sugar, and inflammation. Modern research confirms these traditional uses: leaf extracts rich in triterpenoids and polyphenols reduce blood glucose and metabolic syndrome markers in animal studies [1][2], suppress airway inflammation relevant to asthma and chronic cough [3], and protect the liver and heart from oxidative damage [4]. The leaves are widely available as tea in East Asian markets, making loquat one of the more accessible medicinal plants with genuine scientific backing.

What Makes Loquat Medicinally Active

Loquat leaves contain a distinctive profile of bioactive compounds that collectively explain their broad therapeutic effects:

Triterpenoid acids: Ursolic acid, oleanolic acid, and corosolic acid are the primary active triterpenoids in loquat leaves. These compounds inhibit alpha-glucosidase (an intestinal enzyme that breaks down carbohydrates into glucose), activate PPAR-gamma receptors involved in glucose metabolism, and reduce inflammatory cytokine production via NF-kB pathway inhibition. Corosolic acid in particular is well-studied for blood sugar effects — it also appears in banaba leaf, another traditional antidiabetic plant [5].

Polyphenols and flavonoids: Loquat leaves are rich in chlorogenic acid, quercetin, rutin, and epicatechin. These compounds contribute antioxidant and anti-inflammatory activity, with chlorogenic acid shown to be particularly potent at inhibiting intestinal glucose absorption and improving insulin sensitivity [2].

Sesquiterpene glycosides: Unique to loquat among common fruits, these compounds have demonstrated anti-inflammatory and antitussive (cough-suppressing) activity in animal models. They appear to be responsible for loquat's historical use as a cough remedy in Traditional Chinese Medicine [5].

Amygdalin (small amounts): Present in trace amounts in the leaves, amygdalin contributes mild expectorant properties, consistent with loquat's use in cough syrups across Asia. At culinary doses in tea, it is well within safe limits [5].

Blood Sugar and Metabolic Effects

Loquat leaf extracts have demonstrated consistent blood-glucose-lowering activity across multiple study models. A 2022 study evaluated a standardized aqueous leaf extract (the same preparation as traditional loquat leaf tea) in alloxan-induced diabetic rats, finding significant reductions in fasting blood glucose, triglycerides, and LDL cholesterol alongside increased hepatic glycogen storage [2]. The extract's polyphenol content — primarily chlorogenic acid and quercetin — appeared to drive these effects through alpha-glucosidase inhibition and improved pancreatic beta-cell function.

A complementary 2020 study specifically examined the triterpenoid fraction in high-fat-diet-fed mice with metabolic syndrome [1]. After eight weeks of treatment with loquat leaf triterpenoid acids, the mice showed:

Significantly reduced body weight gain and adipose tissue mass
Lower fasting blood glucose and insulin levels
Reduced serum triglycerides and total cholesterol
Improved HOMA-IR (insulin resistance index)
Upregulation of PPAR-alpha and PPAR-gamma gene expression in liver and adipose tissue

The PPAR activation mechanism is notable because it mirrors the action of thiazolidinedione drugs (a class of type 2 diabetes medication), but through a natural pathway with a different safety profile. Both polyphenol and triterpenoid fractions appear to contribute independently to metabolic improvement.

Practical note: loquat leaf tea prepared by simmering dried leaves (3–5 g in 500 mL water for 10–15 minutes) is the traditional and best-studied form. The leaves should be de-fuzzed (the fine hairs on fresh leaves can irritate the throat) and are typically dried before use.

See our Blood Sugar regulation page and our Berberine page for related approaches to blood glucose management.

Respiratory Health and Airway Inflammation

One of loquat's most established traditional applications is respiratory support — the fruit and leaves appear in classical Chinese herbal formulas (most famously "Pi Pa Gao," or loquat syrup) for cough, asthma, and bronchitis. A 2020 study in the Journal of Ethnopharmacology tested loquat leaf extract in an ovalbumin-induced mouse model of allergic asthma [3]. Findings included:

Significantly reduced eosinophil infiltration into bronchoalveolar lavage fluid (eosinophils drive allergic airway inflammation)
Lower levels of pro-inflammatory cytokines IL-4, IL-5, and IL-13 in lung tissue — the Th2 cytokines central to asthmatic inflammation
Reduced airway mucus hypersecretion, a hallmark of asthma and bronchitis
Attenuated airway hyperresponsiveness to methacholine challenge

The researchers identified the triterpenoid and flavonoid fractions as the primary active components, acting through NF-kB pathway suppression and reduction of mast cell degranulation. The anti-inflammatory mechanism appears non-immunosuppressive in the broad sense — it specifically targets allergic and eosinophilic inflammation rather than general immune suppression, which is clinically relevant for safe long-term use.

For practical respiratory support, loquat syrup (Pi Pa Gao) is available in most Asian grocery stores and is a time-tested preparation. It typically contains loquat leaf extract alongside honey, fritillary bulb, and other botanicals. For those preferring a simpler option, loquat leaf tea alone provides meaningful anti-inflammatory activity.

Liver and Cardiovascular Protection

A 2023 study published in the Saudi Pharmaceutical Journal evaluated loquat leaf extracts against liver and cardiac damage induced by carbon tetrachloride (CCl4) — a model of toxic oxidative injury [4]. Animals treated with loquat leaf extract showed significantly reduced liver enzyme elevations (ALT, AST), lower markers of lipid peroxidation (malondialdehyde), and better preservation of hepatic antioxidant enzymes (superoxide dismutase, catalase) compared to untreated controls. Cardiac tissue histology also showed reduced inflammatory cell infiltration.

The hepatoprotective mechanism involves both direct antioxidant scavenging by the leaf's polyphenols and upregulation of the body's own Nrf2 antioxidant pathway. Ursolic acid's ability to inhibit hepatic stellate cell activation may additionally reduce liver fibrosis progression — a finding consistent with the broader literature on triterpenoids and liver protection.

See our Milk Thistle page for another well-evidenced hepatoprotective plant.

Practical Use

Loquat leaf tea: The most traditional and practical form. Use 3–5 g dried, de-fuzzed leaves per 500 mL water; simmer 10–15 minutes, strain, and drink 1–2 cups daily. Available in Asian grocery stores as "pi pa ye" (枇杷叶).

Loquat syrup (Pi Pa Gao): Ready-to-use preparations for respiratory symptoms. Standard dosing is 1–2 teaspoons 2–3 times daily as needed for cough or throat irritation.

Loquat fruit: The fresh or dried fruit provides polyphenols and beta-carotene, but the therapeutic triterpenoid concentration is substantially higher in the leaves. Eating the fruit is enjoyable and nutritious but provides a different — and lower — dose of the key actives compared to leaf preparations.

Safety: Loquat leaf tea is consumed widely across Asia as a daily beverage and is considered very safe at culinary doses. Fresh leaves contain fine hairs (trichomes) that should be removed or the leaves thoroughly dried before use. Loquat seeds contain significant amygdalin and should not be consumed. There are no established drug interactions, though additive hypoglycemic effects are theoretically possible with diabetes medications at high supplemental doses.

Evidence Review

Triterpenoid Acids and Metabolic Syndrome: High-Fat Diet Mouse Study (Li et al., 2020)

This study isolated the triterpenoid acid fraction from loquat leaves (LLTF) and administered it at 100, 200, and 400 mg/kg/day to C57BL/6J mice with diet-induced metabolic syndrome for eight weeks [1]. The metabolic syndrome model produces a constellation of changes — obesity, insulin resistance, dyslipidemia, and hepatic fat accumulation — closely paralleling human metabolic syndrome.

At 200 and 400 mg/kg, LLTF significantly reduced body weight gain (19% and 28% reduction respectively vs. high-fat control), visceral fat mass, fasting glucose, and fasting insulin. HOMA-IR was reduced dose-dependently. The lipid profile improved substantially: triglycerides fell by approximately 35%, total cholesterol by 22%, and LDL-C by 30% at the highest dose, while HDL-C increased.

Mechanistically, gene expression analysis of liver tissue showed upregulation of PPAR-alpha (governing fatty acid oxidation) and PPAR-gamma (governing insulin sensitivity and adipocyte differentiation) — a dual PPAR agonism effect. The triterpenoids corosolic acid and ursolic acid were identified as the primary active molecules, with corosolic acid being the more potent glucose-lowering agent through AMP-kinase activation.

Limitations: animal model with non-human dosing, no human clinical trials of isolated loquat triterpenoids currently published. Translational value to human supplementation is plausible but not confirmed.

Leaf Aqueous Extract: Antidiabetic Activity and Nutritional Profile (Khouya et al., 2022)

This study characterized the nutritional composition and antidiabetic activity of a standardized aqueous loquat leaf extract (the traditional tea preparation) in alloxan-diabetic rats [2]. The extract was rich in polyphenols (primarily chlorogenic acid and quercetin, quantified by HPLC), with flavonoid content measured at 48.3 mg quercetin equivalents per gram of dried extract.

In diabetic rats, oral administration of the aqueous extract (200 and 400 mg/kg) for 21 days produced dose-dependent reductions in fasting blood glucose (49% and 63% reduction vs. untreated diabetic controls at the two doses), triglycerides (41% and 58%), and LDL cholesterol (29% and 44%). HDL cholesterol increased significantly. Body weight, which decreases in alloxan diabetes due to insulin deficiency, was partially preserved in treated animals.

In vitro alpha-glucosidase inhibition assay showed the extract had an IC50 of 62.4 μg/mL — comparable to acarbose (a prescription alpha-glucosidase inhibitor) at 214 μg/mL, suggesting the extract may actually be more potent than the drug in this assay. This IC50 comparison, while preliminary, supports the mechanism of intestinal carbohydrate absorption inhibition. Toxicity assessment found no adverse effects at 2000 mg/kg acute dose, suggesting a high safety margin.

Airway Inflammation in Asthma Model: Anti-Allergic Activity (Kim et al., 2020)

This study used an ovalbumin (OVA)-sensitization and challenge protocol in mice to model human allergic asthma — the most widely used preclinical model for evaluating asthma interventions [3]. Loquat leaf extract (EJ-Extract, standardized to ursolic acid content) was administered orally at 100 and 200 mg/kg for two weeks concurrent with OVA challenge.

Key outcomes at 200 mg/kg: total cell count in bronchoalveolar lavage (BAL) fluid decreased by 64% vs. OVA-only controls; eosinophil count decreased by 71%; IL-4, IL-5, and IL-13 (Th2 cytokines driving allergic inflammation) fell by 55–68%; and serum OVA-specific IgE (a marker of allergic sensitization) decreased by 42%. Airway hyperresponsiveness, measured as enhanced pause (Penh) in response to methacholine, was significantly attenuated.

Histological examination of lung tissue showed markedly reduced goblet cell metaplasia (mucus-producing cell overgrowth) and inflammatory cell infiltration. Western blotting of lung tissue homogenates confirmed NF-kB pathway suppression as the primary signaling mechanism.

The study used a well-validated model and included multiple mechanistic endpoints, providing a strong preclinical case for loquat leaf's anti-asthmatic activity. Human clinical trials have not been published for EJ leaf extract specifically in asthma, though Pi Pa Gao (the traditional loquat cough formula) has been used clinically in China and Japan for centuries with a strong empirical safety record.

Liver and Cardiac Protection Against Oxidative Injury (Shahat et al., 2023)

This study used a CCl4-induced acute hepatotoxicity model in rats — a standard model for evaluating hepatoprotective compounds — to test two fractions of loquat leaf: an ethanol extract and a chloroform fraction [4]. CCl4 causes free radical-mediated oxidative damage to hepatocytes and cardiomyocytes.

Animals pretreated with loquat leaf extracts showed substantially lower serum ALT (alanine aminotransferase), AST (aspartate aminotransferase), and ALP (alkaline phosphatase) compared to CCl4-only controls — these enzymes are markers of hepatocyte membrane damage. The degree of protection was significant: ALT fell from approximately 280 to 95 U/L in the ethanol extract group, compared to a normal range of ~40 U/L in healthy controls.

Lipid peroxidation (malondialdehyde) in liver and cardiac tissue was reduced by 48% and 39% respectively, while antioxidant enzyme activities (SOD, CAT, GSH peroxidase) were significantly preserved. Histological sections showed reduced hepatocyte necrosis and inflammatory infiltration. The chloroform fraction — enriched in triterpenoids — showed greater hepatoprotective activity than the less-purified ethanol extract, suggesting triterpenoids as the primary protective agents.

Limitations: acute toxicity model with pharmacological doses of CCl4; does not directly model typical human liver stressors like alcohol or non-alcoholic fatty liver disease. However, the findings are consistent with the broader triterpenoid hepatoprotection literature and support traditional use claims.

Comprehensive Phytochemistry and Pharmacology Review (Zhu et al., 2022)

This systematic review in the Journal of Ethnopharmacology catalogued the full range of documented uses, chemical constituents, and pharmacological activities of Eriobotrya japonica leaves based on published research through 2022 [5]. The review identified over 60 distinct bioactive compounds in the leaves, classified into: triterpenoids (primarily ursolic acid, oleanolic acid, corosolic acid, 2-alpha-hydroxyursolic acid), flavonoids (quercetin, rutin, kaempferol, chlorogenic acid), sesquiterpene glycosides, and polysaccharides.

Documented pharmacological activities reviewed: antidiabetic, anti-inflammatory, antioxidant, antitumor (primarily in vitro), hepatoprotective, antiviral, and antitussive/expectorant. The antidiabetic evidence was strongest, with multiple animal studies converging on consistent glucose-lowering activity through diverse mechanisms (alpha-glucosidase inhibition, PPAR activation, AMPK activation, and insulin sensitization). The anti-inflammatory evidence was also robust. Antitumor findings were largely in vitro and require substantial further research before clinical relevance can be assessed.

The review identified a notable gap: despite extensive traditional use and promising preclinical data, there are very few published human clinical trials specifically evaluating loquat leaf extracts. This limits definitive efficacy claims but does not undermine the biological plausibility of the traditional uses — the mechanisms are well-characterized, and the safety record from centuries of tea consumption is reassuring. The authors recommended human trials particularly for blood glucose management and respiratory conditions as highest-priority research areas.

Evidence Strength Summary

The anti-inflammatory and blood-sugar-lowering effects of loquat leaf are supported by multiple converging animal studies using different models and different extract fractions, with consistent and plausible mechanisms. The hepatoprotective effects are supported by well-controlled oxidative stress studies. The respiratory benefits align with both traditional use and mechanistic anti-inflammatory data in an established asthma model. The critical limitation across all areas is the absence of human randomized controlled trials — the evidence base is preclinical with supportive historical use, not yet clinically confirmed in humans. Loquat leaf tea is a reasonable choice for those seeking a traditional, safe herbal option for blood sugar support, respiratory inflammation, or liver health, with the expectation that human trial data may strengthen (or qualify) these findings over the coming years.

References

Eriobotrya japonica leaf triterpenoid acids ameliorate metabolic syndrome in C57BL/6J mice fed with high-fat dietLi F, Li Y, Li Q, Shi X. Biomedicine & Pharmacotherapy, 2020. PubMed 33113426 →
Loquat (Eriobotrya japonica (Thunb) Lindl.): Evaluation of nutritional value, polyphenol composition, antidiabetic effect, and toxicity of leaf aqueous extractKhouya T, Ramchoun M, Elbouny H, Hmidani A, Bouhlali EDT, Alem C. Journal of Ethnopharmacology, 2022. PubMed 35718052 →
Eriobotrya japonica leaf extract attenuates airway inflammation in ovalbumin-induced mice model of asthmaKim TM, Paudel KR, Kim DW. Journal of Ethnopharmacology, 2020. PubMed 31310829 →
Cardioprotective study of Eriobotrya japonica leaf extracts against carbon tetrachloride induced toxicity in ratsShahat AA, Ullah R, Alqahtani AS, Fantoukh OI. Saudi Pharmaceutical Journal, 2023. PubMed 38033747 →
Traditional uses, phytochemistry, pharmacology, and toxicity of Eriobotrya japonica leaves: A summaryZhu X, Wang L, Zhao T, Jiang Q. Journal of Ethnopharmacology, 2022. PubMed 35870687 →